HI
PPH icon

Harbour Investments’s VanEck Pharmaceutical ETF PPH Stock Holding History

Harbour Investments’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$485K Sell
4,433
-123
-3% -$12.7K 0.01% 1134
2026
Q1 		$473K Buy
4,556
+90
+2% +$9.59K 0.01% 1084
2025
Q4 		$461K Buy
4,466
+329
+8% +$32K 0.01% 889
2025
Q3 		$374K Sell
4,137
-313
-7% -$27.4K 0.01% 937
2025
Q2 		$391K Buy
4,450
+394
+10% +$34.2K 0.01% 870
2025
Q1 		$370K Buy
4,056
+532
+15% +$47.9K 0.01% 836
2024
Q4 		$304K Buy
3,524
+99
+3% +$8.96K 0.01% 864
2024
Q3 		$325K Buy
3,425
+488
+17% +$46.3K 0.01% 817
2024
Q2 		$269K Buy
2,937
+5
+0.2% +$446 0.01% 834
2024
Q1 		$266K Buy
2,932
+1,275
+77% +$112K 0.01% 811
2023
Q4 		$135K Buy
1,657
+637
+62% +$49.9K 0.01% 1017
2023
Q3 		$81.5K Hold
1,020
– – ﹤0.01% 1125
2023
Q2 		$80.4K Hold
1,020
– – ﹤0.01% 1146
2023
Q1 		$79.2K Hold
1,020
– – ﹤0.01% 1150
2022
Q4 		$79.3K Hold
1,020
– – ﹤0.01% 1116
2022
Q3 		$78K Hold
1,020
– – 0.01% 1089
2022
Q2 		$78K Buy
+1,020
New +$79.6K 0.01% 1089
2021
Q4 		$79K Sell
1,020
-1,329
-57% -$98.8K ﹤0.01% 1071
2021
Q3 		$171K Buy
2,349
+5
+0.2% +$373 0.01% 1104
2021
Q2 		$171K Buy
2,344
+7
+0.3% +$499 0.01% 1123
2021
Q1 		$161K Buy
+2,337
New +$161K 0.01% 1072

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Harbour Investments's PPH Position: Q2 2026 in Review

Harbour Investments reduced its VanEck Pharmaceutical ETF (PPH) stake by 2.7% in Q2 2026, selling an estimated $12.7K and leaving 4,433 shares worth $485K. The position accounts for 0.01% of the portfolio, ranked #1134.

Harbour Investments first reported a position in PPH in Q1 2021 and has held it in 21 quarters since. 147 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • Harbour Investments held 4,433 shares of VanEck Pharmaceutical ETF worth $485K as of Q2 2026.
  • Harbour Investments sold 123 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $12.7K.
  • VanEck Pharmaceutical ETF made up 0.01% of Harbour Investments's portfolio in Q2 2026, its #1134 holding.
  • Harbour Investments first reported a position in VanEck Pharmaceutical ETF in Q1 2021 and has held it in 21 quarters since.
  • 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.